Skip to main content

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

13F holders, Q1 2022

Institutional positions in Relay Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
140
+11 vs. Q4 2021
Shares held
113.1M
+2.30M (+2.1%) vs. Q4 2021
Total value
$3.38B
−$17.7M (−0.5%) vs. Q4 2021
New holders
26
45 more added
Sold out
15
38 more reduced

2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RLAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 140 institutions
Q1 2021: 137 institutionsQ2 2021: 125 institutionsQ3 2021: 132 institutionsQ4 2021: 131 institutionsQ1 2022: 140 institutionsQ2 2022: 148 institutionsQ3 2022: 162 institutionsQ4 2022: 165 institutionsQ1 2023: 157 institutionsQ2 2023: 161 institutionsQ3 2023: 172 institutionsQ4 2023: 177 institutionsQ1 2024: 189 institutionsQ2 2024: 179 institutionsQ3 2024: 195 institutionsQ4 2024: 200 institutionsQ1 2025: 208 institutionsQ2 2025: 208 institutionsQ3 2025: 199 institutionsQ4 2025: 227 institutionsQ1 2026: 244 institutionsQ2 2026: 259 institutions
Value heldQ1 2022: $3.38B
Q1 2021: $2.96BQ2 2021: $3.26BQ3 2021: $2.89BQ4 2021: $3.41BQ1 2022: $3.38BQ2 2022: $2.02BQ3 2022: $2.76BQ4 2022: $1.91BQ1 2023: $2.16BQ2 2023: $1.64BQ3 2023: $1.10BQ4 2023: $1.40BQ1 2024: $1.10BQ2 2024: $826.8MQ3 2024: $1.16BQ4 2024: $675.8MQ1 2025: $438.1MQ2 2025: $591.8MQ3 2025: $867.4MQ4 2025: $1.47BQ1 2026: $1.83BQ2 2026: $4.58B
Institutions holding RLAY and their total value by quarter
QuarterHoldersValue
Q2 2026259$4.58B
Q1 2026244$1.83B
Q4 2025227$1.47B
Q3 2025199$867.4M
Q2 2025208$591.8M
Q1 2025208$438.1M
Q4 2024200$675.8M
Q3 2024195$1.16B
Q2 2024179$826.8M
Q1 2024189$1.10B
Q4 2023177$1.40B
Q3 2023172$1.10B
Q2 2023161$1.64B
Q1 2023157$2.16B
Q4 2022165$1.91B
Q3 2022162$2.76B
Q2 2022148$2.02B
Q1 2022140$3.38B
Q4 2021131$3.41B
Q3 2021132$2.89B
Q2 2021125$3.26B
Q1 2021137$2.96B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Relay Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding RLAY in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Baillie Gifford & Co244,277$7.31M0.01%+19,236+8.5%Added
Gilder Gagnon Howe & Co LLC274,283$8.21M0.08%−522,464−65.6%Reduced
Bank of New York Mellon Corp286,886$8.59M0.00%+5,958+2.1%Added
HarbourVest Partners LLC296,402$8.87M1.81%00.0%Unchanged
Goldman Sachs Group Inc300,771$9.00M0.00%−142,230−32.1%Reduced
Sessa Capital IM, L.P.301,200$9.02M0.55%+301,200New
Artisan Partners Limited Partnership304,054$9.10M0.01%+304,054New
Integral Health Asset Management, LLC327,000$9.79M2.55%+102,000+45.3%Added
Woodline Partners LP331,663$9.93M0.16%+76,062+29.8%Added
Candriam Luxembourg S.C.A.411,416$12.3M0.08%−118,469−22.4%Reduced
Morgan Stanley431,480$12.9M0.00%−92,013−17.6%Reduced
Nextech Invest AG475,485$14.2M4.06%+475,485New
Harvard Management Co Inc541,124$16.2M1.63%00.0%Unchanged
Charles Schwab Investment Management Inc544,590$16.3M0.00%+16,572+3.1%Added
Ra Capital Management, L.P.549,055$16.4M0.36%00.0%Unchanged
UBS Asset Management Americas Inc574,447$17.2M0.01%−40,811−6.6%Reduced
Bessemer Group Inc584,463$17.5M0.04%00.0%Unchanged
Rock Springs Capital Management LP601,667$18.0M0.45%+3,900+0.7%Added
Northern Trust Corp650,351$19.5M0.00%−34,039−5.0%Reduced
Artal Group S.A.700,000$21.0M0.89%−50,000−6.7%Reduced
Norges Bank937,926$28.1M0.01%+117,926+14.4%Added
Geode Capital Management, LLC1,352,477$40.5M0.01%+47,461+3.6%Added
Alphabet Inc.1,568,753$47.0M1.52%+4,580+0.3%Added
Alliancebernstein L.P.1,808,950$54.1M0.02%+63,323+3.6%Added
Perceptive Advisors LLC1,943,097$58.2M1.21%00.0%Unchanged
Wellington Management Group LLP2,020,514$60.5M0.01%+21,966+1.1%Added
ArrowMark Colorado Holdings LLC2,025,114$60.6M0.53%−8,210−0.4%Reduced
EcoR1 Capital, LLC2,291,441$68.6M2.15%+512,357+28.8%Added
Boxer Capital, LLC2,669,132$79.9M4.11%00.0%Unchanged
State Street Corp3,253,692$97.4M0.00%+67,170+2.1%Added
JPMorgan Chase & Co3,274,389$98.0M0.01%−92,923−2.8%Reduced
Casdin Capital, LLC3,857,253$115.4M5.18%00.0%Unchanged
Bellevue Group AG3,918,962$117.3M1.36%−187,000−4.6%Reduced
Driehaus Capital Management LLC4,050,688$121.2M1.49%+16,332+0.4%Added
BVF Inc4,530,605$135.6M5.42%+1,400,000+44.7%Added
Price T Rowe Associates Inc4,999,718$149.6M0.02%+844,377+20.3%Added
BlackRock Inc.5,974,183$178.8M0.00%−19,430−0.3%Reduced
Vanguard Group Inc6,217,623$186.1M0.00%+19,181+0.3%Added
FMR LLC16,242,006$486.1M0.04%+35,405+0.2%Added
SB Investment Advisers (UK) Ltd27,904,963$835.2M3.96%00.0%Unchanged
Federated Hermes, Inc.0$00.00%−600,000−100.0%Sold out
Fred Alger Management, LLC0$00.00%−177,771−100.0%Sold out
Toronto Dominion Bank0$00.00%−55,643−100.0%Sold out
Ratan Capital Management LP0$00.00%−50,000−100.0%Sold out
AlphaCrest Capital Management LLC0$00.00%−14,253−100.0%Sold out
Brown Advisory Inc0$00.00%−12,914−100.0%Sold out
Jump Financial, LLC0$00.00%−10,700−100.0%Sold out
Allstate Corp0$00.00%−8,600−100.0%Sold out
XTX Topco Ltd0$00.00%−7,174−100.0%Sold out
Marshall Wace, LLP0$00.00%−2,499−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−871−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−453−100.0%Sold out
Quantbot Technologies LP0$00.00%−100−100.0%Sold out
Parallel Advisors, LLC0$00.00%−71−100.0%Sold out
Captrust Financial Advisors0$00.00%−10−100.0%Sold out
Grace Capital––––Not filed
Bell Investment Advisors, Inc––––Not filed